Results 341 to 350 of about 8,792,528 (401)

Evaluation of Treatment Outcomes of High‐Risk Gestational Trophoblastic Neoplasms (GTNs)

Natural Sciences, EarlyView.
ABSTRACT This study was performed to assess the efficacy, safety, and prognostic factors of treatment protocols in patients with high‐risk gestational trophoblastic neoplasia (GTN). Data of 64 high‐risk GTN patients treated at our clinic between January 1993 and December 2020 were retrospectively analyzed. Patients were classified according to the FIGO
Ayberk Çakır, Fulya Kayıkçıoğlu, Gürkan Özbey, Edis Kahraman   +3 more
wiley   +1 more source

Visfatin (NAMPT) expression in human placenta cells in normal and pathological conditions and its hormonal regulation in trophoblast JEG-3 cells. [PDF]

PLoS One
Dawid M, Kurowska P, Pawlicki P, Kotula-Balak M, Milewicz T, Dupont J, Rak A.   +6 more
europepmc   +1 more source

Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public Healthcare

Prenatal Diagnosis, EarlyView.
ABSTRACT Objective To describe the implementation of whole genome sequencing (WGS) in prenatal diagnostics and outline the national guideline system facilitating this. Methods Clinical guidelines for WGS in prenatal diagnostics were developed and implemented by the Danish Fetal Medicine Society.
Ida Vogel, Lotte Andreasen, Marie Balslev‐Harder, Naja Becher, Anja Ernst, Kasper Gadsbøll, Tina Duelund Hjortshøj, Marie Skov Hvidbjerg, Martin Larsen, Stina Lou, Ida Charlotte Bay Lund, Lars Henning Pedersen, Laura Kirstine Sønderberg Roos, Lene Sperling, Lone Sunde, Pernille Mathiesen Tørring, Cathrine Vedel, Olav Bjørn Petersen   +17 more
wiley   +1 more source

Velocity-selective arterial spin labeling perfusion measurements in 2nd trimester human placenta with varying BMI. [PDF]

Placenta
Seiter D, Chen R, Ludwig KD, Zhu A, Shah D, Wieben O, Johnson KM.   +6 more
europepmc   +1 more source

Hemophilia A: An Ideal Disease for Prenatal Therapy

Prenatal Diagnosis, EarlyView.
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada, Anthony Atala, Graça Almeida‐Porada   +2 more
wiley   +1 more source

Ultrasound Microvessel Imaging of the Human Placenta Demonstrates Altered Vessel Densities in Fetal Growth Restriction With Vascular and Immune Pathologies: A Pilot Case-Control Study. [PDF]

J Ultrasound Med
Lok UW, Scott HM, Tang S, Santos J, Gong P, Huang C, Pone KA, Nienow MK, Ruka KL, Breutzman EN, Cheek-Norgan EH, Branda ME, Ruano R, Quintin RA, Schenone MH, Chen S, Enninga EAL.   +16 more
europepmc   +1 more source

Revealing the molecular landscape of human placenta: a systematic review and meta-analysis of single-cell RNA sequencing studies. [PDF]

Hum Reprod Update
Derisoud E, Jiang H, Zhao A, Chavatte-Palmer P, Deng Q.   +4 more
europepmc   +1 more source

Placental transfer of tofacitinib in the ex vivo dual-side human placenta perfusion model. [PDF]

Curr Res Toxicol
Eliesen GAM, Fransen M, van Hove H, van den Broek PHH, Greupink R.   +4 more
europepmc   +1 more source

Placental malaria is associated with a TLR–Endothelin-3–oxidative damage response in human placenta tissues

Chenge S, Mbalitsi M, Ngure H, Obimbo M, Singoei M, Kangogo M, Kanoi BN, Gitaka J, Kobia FM.   +8 more
europepmc   +1 more source